MK
Martin Kampmann is a researcher at the University of California, San Francisco. His work develops and applies CRISPR-based functional genomics to study neurodegenerative diseases such as Alzheimer's and Parkinson's. He has contributed to understanding cellular pathways and genetic modifiers of neurodegeneration.
- Field
- Biology · Genetics
- Clarivate categories
- Cross-Field
- Affiliation
- University of California San Francisco, United States